Built by Elekta & Philips, the pioneers in the field, MR Linac has the most powerful high-field (1.5 Tesla) MRI system and next-generation linear accelerator technology.
Yashoda Hospitals is the First and Only Hospital in India to have this superior, revolutionary technology.
MR Linac (Magnetic Resonance Linear Accelerator) is an innovative technology that combines a magnetic resonance imaging (MRI) device with a linear accelerator, offering a groundbreaking approach to cancer treatment. This technology allows for real-time visualisation of the tumour during radiotherapy, providing precise monitoring and positioning of the radiation beams directly over the tumour.
MR Linac integrates MRI and radiotherapy to treat various types of cancer, particularly those affecting soft tissues. Unlike traditional systems, the MR-Linac delivers radiation beams while simultaneously monitoring the target area using MRI. This unique combination of technologies empowers physicians to have exceptional control over radiation delivery by visualising internal anatomy and the tumour in real time. They can personalise and adapt each treatment with unprecedented precision and accuracy.
By merging a high-strength MRI machine with a linear accelerator, the MR-Linac enables highly accurate radiation treatment in a single device. The MRI component produces high-definition, real-time images of the tumour, while the linear accelerator maintains precise focus on the tumour, delivering targeted high-energy beams. This synergy between MRI and radiotherapy ensures unparalleled accuracy and effectiveness in delivering radiation treatment to patients.
MR Linac technology, a breakthrough in radiotherapy applications, allows for adaptive monitoring of the changes in the size and shape of the tumour before and during treatment, enabling precise delivery of high doses of radiation to the tumour.
With superior imaging capabilities compared to CT, the 1.5 Tesla MR-Linac device provides detailed visualisation of tumours, surrounding tissue, edema, and inflammation. This high-definition MRI-based radiation therapy allows for accurate tumour demarcation and personalised targeting of tumour cells while sparing normal tissue.
The advantages of MR Linac technology lead to significantly improved clinical outcomes, including improved local control, decreased toxicity, and a shorter course of treatment, thereby expanding the scope of radiotherapy.
Prostate Cancer
Head & Neck Cancer
Rectum Cancer
Pancreatic Cancer
Breast Cancer
Brain Cancer
Bladder Cancer
Liver Cancer
Lung Cancer
Gynecologic Cancer
Cholangiocarcinoma
Stomach Cancer
Due to body functions or changes in body composition, many tumours move during treatment and in between sessions. With its fast real-time visualisation capabilities, MR Linac helps to continually monitor these changes and re-optimize treatment plans.
Every patient has unique treatment needs, and by visualising the tumour's position, size, and shape, MR Linac ensures high-precision tumour targeting while minimising damage to surrounding tissues.
With real-time adaptive capabilities, radiation is delivered with continuous target visualisation throughout the treatment process, allowing for real-time adaptation and adjustment of treatment plans to ensure optimal outcomes.
MR Linac provides a comprehensive 360-degree view of the patient, leaving no room for the tumour to hide. This allows for accurate targeting of the tumour and delivers precise treatment.
Enabled with intelligent software, MR Linac provides enhanced soft-tissue contrast and functional information for optimised radiotherapy treatment. This AI-powered technology ensures the most effective and personalised care.
MR Linac's high field MRI provides pinpoint accuracy, unparalleled soft tissue contrast, and real-time imaging for tumour tracking and targeting during radiation therapy.
MR-Linac allows for daily dose reshaping and treatment adaptation, maximising the radiation dose delivered to the tumour while minimising radiation exposure to surrounding healthy tissue, lowering the risk of complications, and improving progression-free survival rates.
With optimised radiotherapy treatment enabled by real-time visualisation and adaptive personalization, MR Linac is designed to deliver the best possible treatment outcomes.
When receiving treatment with MR Linac, your clinical team will provide a detailed explanation of the treatment process. Here is a concise overview of what you can expect:
Step
Before starting radiation therapy, your doctor will discuss treatment options, potential side effects, and address your questions or concerns.
Step
Special images of the body's interior using CT scans or MRI scans will provide information about the tumour's location, size, shape, and nearby organs.
Step
The expert team will determine the prescribed radiation dose as well as the precise radiation delivery sites by creating an individualised treatment plan.
Step
At the start of each session, a new MRI scan will be conducted and compared to the planning scans, and adjustments to the treatment plan will be made accordingly.
After each treatment session, you can go home. Following the completion of radiation therapy, regular follow-up appointments will be scheduled for up to five years to monitor your condition. Attending these appointments is crucial, even if you feel well.
Our dedicated team at Yashoda Hospitals is committed to providing you with the highest standard of care using this advanced technology.
Sr.Consultant-Radiation Oncologist & Clinical Director-Academics (Radiation Oncology)
Sr.Consultant Radiation Oncologist
Consultant Radiation Oncologist
Consultant Radiation Oncologist
Consultant Radiation Oncologist
Sr.Consultant Radiation Oncologist
Sr.Consultant Radiation Oncologist
Consultant Radiation Oncologist
“MR Linac at Yashoda Hospitals is the first of its kind in India, offering state-of-the-art technology that is transforming healthcare by integrating advanced imaging with radiation therapy, enabling medical professionals across multiple specialties to deliver personalised and precise treatments for enhanced patient care.”
